Start the conversation
All we've heard for the last month or so is how the market is undergoing a tremendous rotation between sectors.
The migration of money from perceived overvalued groups into better values has changed the performance landscape, but is it worth following the crowd?
In most cases, I preach that being part of the crowd is one of the more dangerous moves.
This is because crowded trades tend to be so at their tops, not bottoms. But in a small number of cases, a few of the leading sectors are showing signs that they've yet to become crowded trades.
The following table displays the top-performing, widely traded ETFs since the beginning of July.
The sector rotation has prices in healthcare and related groups outperforming the market. These, of course, had been some of the market's underperforming sectors for some time.
Topping the list is the SPDR S&P Pharmaceutical ETF, which has left the market in the dust over the last month or so, returning more than 12%.